Spear Therapeutics' Acquisition

Spear Therapeutics was acquired by Incanthera on February 06, 2015.

Spear Therapeutics based in Leicester, is behind the discovery of a novel prodrug mechanism enabling specific targeting and killing of cancer cells.…

Articles about Spear Therapeutics' Acquisition: